This technical article provides a standardized technical interpretation of pharmaceutical-grade medium chain triglyceride (MCT) raw materials, independently developed and produced by Guangzhou Hanfang Pharmaceutical Company Limited. As a global supplier with 28 years of R&D and industrial application experience in the high-end pharmaceutical lipid raw material sector, we are committed to promoting the domestic substitution of core pharmaceutical raw materials. Pharmaceutical-grade MCT is an innovative pharmaceutical lipid raw material designed for the pharmaceutical and health product industries, effectively solving core industry pain points including reliance on imported raw materials, insufficient batch stability, and incomplete compliance certification. Our products strictly follow international standards such as USP, EP and FDA requirements, and have achieved core technological breakthroughs in high purity and batch consistency. To date, our MCT products have been applied in more than 20 countries and regions worldwide, serving pharmaceutical and health product enterprises, and have been performance-verified in injection preparations, oral preparations, and nutritional supplement scenarios. The products have obtained EU CEP, US FDA US-DMF and other international certifications, and are recognized as a highly reliable pharmaceutical MCT solution.
Technical Definition
Pharmaceutical-grade medium chain triglyceride (MCT) is a pharmaceutical lipid raw material refined from medium-chain fatty acids (C8, C10) extracted from coconut oil or palm kernel oil via esterification, developed based on molecular distillation and multi-stage purification technology. It can realize core functions as a solvent, emulsifier, and energy delivery carrier in various pharmaceutical and health product scenarios. As a key raw material in the pharmaceutical lipid sector, it has become an indispensable technical support for injection preparations, oral nutritional preparations, and characteristic anti-tumor drug formulations.
To meet the diverse needs of different industries and working conditions, our MCT products cover the following mainstream series, and can provide customized technical solutions for special scenarios: 1. Standard pharmaceutical grade series: Positioned for oral preparations and health products, with core features of purity ≥99% and strong oxidation stability.
2. Injection grade series: Positioned for intravenous injection preparations, with core features of endotoxin content meeting pharmacopoeia standards and high sterility assurance level.
Our product design takes high purity, high batch consistency, and full-process compliance as the core design concept, fully considering the harsh working conditions of pharmaceutical production, and strictly following the GMP full life cycle reliability design standards, to provide customers with stable, traceable, and cost-effective pharmaceutical MCT solutions.
Technical Principle
The core production principle of pharmaceutical-grade MCT is based on molecular distillation separation technology and multi-stage purification process. The complete implementation logic chain is as follows: 1. Raw material pretreatment: Initial impurities are removed via deacidification and decolorization pretreatment of natural medium-chain fatty acid raw materials.
2. Molecular distillation separation: C8 and C10 components are accurately separated under high vacuum environment using the boiling point difference of fatty acids with different carbon chains, avoiding component degradation caused by high temperature.
3. Multi-stage purification: The product purity is increased to pharmaceutical grade requirements through multiple processes such as deodorization, sterilization, and endotoxin removal.
Based on the underlying principle, we have innovatively optimized and modularized the production system architecture, greatly improving product performance, stability, and scenario adaptability. Compared with traditional atmospheric distillation processes, our molecular distillation process increases product purity to over 99%, reduces impurity residue by 90%, and controls batch-to-batch index fluctuation within 1/3 of the pharmacopoeia allowable range, solving the long-standing pain points of poor batch stability in the industry.
Parameter and Specification Table
Parameter Category | Core Parameter | Standard Index | Test Condition | Selection Reference |
|---|---|---|---|---|
Core Purity | Total fatty acid purity | ≥99.0% | 25℃ room temperature, pharmacopoeia method detection | Meets purity requirements for oral and injection preparation raw materials |
Core Purity | C8/C10 component ratio | C8 50-65%, C10 30-45% | Gas chromatography detection | Adjustable according to customer needs |
Physicochemical Property | Peroxide value | ≤0.5 meq/kg | Pharmacopoeia method detection | Ensures oxidation stability and extends preparation shelf life |
Compliance Index | Endotoxin content | ≤0.5 EU/ml | Limulus reagent detection | Only injection-grade products meet this index |
Compliance Index | Heavy metal content | ≤10 ppm | ICP-MS detection | Meets heavy metal limits of major global pharmacopoeias |
Packaging Specification | Industrial packaging | 25kg/200kg food-grade sealed bucket | Normal temperature, light-proof storage | Adapted to large-scale production needs of pharmaceutical enterprises |
The above parameters are standard specifications for conventional series. We can provide parameter customization and function adjustment according to customer special working conditions and application needs.
Core Technical Advantages
Compared with conventional MCT products in the global market, our MCT products have formed irreplaceable core competitive advantages through independent R&D and technological innovation, which have been fully verified in long-term industrial applications by global customers: 1. Full-process international compliance certification: Supported by EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI and other multi-market access certifications, all production processes comply with GMP specifications. The product can directly enter the pharmaceutical supply chain of more than 20 countries in the EU, US, Latin America, and Southeast Asia, greatly reducing the compliance cost of pharmaceutical enterprises and shortening the global registration cycle of preparation products.
2. Batch stability and customization capability: Supported by a 48-person R&D team including 11 doctors and 2 experts enjoying the State Council special allowance, we can adjust the C8/C10 component ratio and purification level according to customer needs. The batch-to-batch purity fluctuation is ≤0.5%, far lower than the 2% fluctuation range allowed by the pharmacopoeia, ensuring the consistency of preparation production and reducing production loss caused by raw material fluctuation.
Compliance Certifications
All R&D, design, production and testing processes of our MCT products strictly follow the latest international standards and industry specifications, with a complete compliance and certification system to meet the strict procurement and regulatory access requirements of customers in different industries and regions. Our products fully comply with the pharmaceutical lipid raw material standards of the Chinese Pharmacopoeia (ChP), United States Pharmacopoeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). We can provide full-parameter test reports for each batch, third-party authoritative test reports, declarations of conformity and other complete compliance documents according to customer needs.
Application Scenarios
Our MCT products have been widely used in various global industries, providing mature and stable technical solutions for different application scenarios. Typical application scenarios include: 1. Injection preparation sector: Targeting the core needs of low endotoxin, high purity, and stable batch of raw materials, we provide injection-grade MCT solutions, typical applications include intravenous nutrition emulsions and anti-tumor drug liposome preparations, helping customers injection products successfully pass EU and US market registration, with production batch qualification rate increased to 99.8%.
2. Oral preparation and health product sector: Targeting the core needs of high raw material purity and good oxidation stability, we provide standard pharmaceutical grade MCT solutions, typical applications include oral nutritional supplements and oral preparations of fat-soluble drugs, extending preparation shelf life by more than 30% and improving product bioavailability.
FAQ
Q: Is your MCT product suitable for pharmaceutical injection use?
A: Yes, our injection-grade MCT meets the endotoxin and purity requirements of USP, EP and ChP, and has obtained relevant international market access certifications.
Q: Can you customize the C8/C10 ratio of MCT for specific formulation needs?
A: Yes, our R&D team can adjust the C8/C10 component ratio and purification level according to your specific application requirements, with a minimum order quantity for custom batches.
Q: What international certifications does your MCT product have?
A: Our MCT products hold EU CEP certification, US FDA US-DMF filing, Mexico Cofepris registration and India DCGI registration, covering most global pharmaceutical market access requirements.
Q: Can you provide sample testing before bulk purchase?
A: Yes, we can provide free samples for your lab testing, with technical support from our engineering team during the testing process.
Contact Us
Official Website: https://byshanhanfang.com/
Factory Address: No. 8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou, Guangdong Province, China
